March 15, 2026 a 09:31 am
Healthcare Stocks - Performance Analysis
📊 The healthcare sector has shown mixed performance over recent periods. Notable divergences have been observed, with some stocks demonstrating resilience while others have faced challenges. This analysis delves into the short-term (1 week), medium-term (1 month), and longer-term (3 months) performance of top healthcare stocks, providing insights and guidance for future investments.
Healthcare Stocks Performance One Week
| Stock | Performance (%) | Performance |
|---|---|---|
| JNJ | 0.47% | |
| MRK | -0.15% | |
| LLY | -0.49% | |
| AMGN | -0.85% | |
| ABT | -1.32% | |
| UNH | -1.48% | |
| ISRG | -3.67% | |
| ABBV | -4.58% | |
| TMO | -7.64% |
Healthcare Stocks Performance One Month
| Stock | Performance (%) | Performance |
|---|---|---|
| AMGN | -0.59% | |
| JNJ | -0.71% | |
| ISRG | -2.66% | |
| UNH | -3.56% | |
| ABT | -4.02% | |
| MRK | -4.68% | |
| ABBV | -5.02% | |
| LLY | -5.10% | |
| TMO | -8.05% |
Healthcare Stocks Performance Three Months
| Stock | Performance (%) | Performance |
|---|---|---|
| MRK | 14.95% | |
| AMGN | 12.94% | |
| JNJ | 12.34% | |
| ABBV | -2.65% | |
| LLY | -5.70% | |
| ISRG | -16.27% | |
| ABT | -16.39% | |
| UNH | -15.87% | |
| TMO | -20.65% |
Summary
💡 The healthcare sector revealed various performance trends across different time periods. In the short-term (one week), Johnson & Johnson and Merck were relatively stable, while Thermo Fisher Scientific showed significant underperformance. Over the one-month horizon, Amgen showed resilience; however, the sector largely faced challenges, evident from the negative performance trends. Notably, over a three-month period, Merck exhibited the strongest performance, whereas Abbott Laboratories and Intuitive Surgical witnessed considerable declines. Investors should consider these trends when making strategic decisions, acknowledging the volatility and potential for recovery or further decline within this sector.